The angiotensin II receptor antagonist irbesartan for the treatment of portal hypertension: A placebo controlled, double-blind study.

被引：0
|
作者：
Schepke, M [1 ]
Werner, E [1 ]
Bieker, E [1 ]
Schiedermaier, P [1 ]
Hofer, U [1 ]
Layer, G [1 ]
Heller, J [1 ]
Neef, M [1 ]
Sauerbruch, T [1 ]
机构：
[1] Univ Bonn, D-5300 Bonn, Germany
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
985
引用
收藏
页码：406A / 406A
页数：1
相关论文
共 50 条
  • [21] The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania: Results of a Double-blind, Placebo-controlled Study
    Grant, Jon E.
    Odlaug, Brian
    Kim, Suck Won
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S354 - S355
  • [22] The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania Results of a Double-Blind, Placebo-Controlled Study
    Grant, Jon E.
    Odlaug, Brian L.
    Schreiber, Liana R. N.
    Kim, Suck Won
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 134 - 138
  • [23] Hydroxycloroquine (HCQ) in lupus pregnancy:: Double-blind placebo controlled study.
    Levy, RA
    Jesús, NR
    Vilela, V
    Albuquerque, EMN
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S241 - S241
  • [24] Effects of the angiotensin II receptor antagonist irbesartan on the endothelial function in patients with hypertension
    Koval, SN
    Mysnichenko, OV
    Maslyaeva, LV
    Starchenko, TG
    JOURNAL OF HYPERTENSION, 2000, 18 : S156 - S156
  • [25] 7-MEOTA in the treatment of tardive dyskinesia. Double-blind placebo controlled study.
    Marsalek, M
    Filip, V
    Petrovsky, M
    Klar, I
    Filipova, M
    Klaschka, J
    HOMEOSTASIS IN HEALTH AND DISEASE, 1997, 38 (01): : 7 - 7
  • [26] Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study
    Reverter, Enric
    Mesonero, Francisco
    Seijo, Susana
    Martinez, Javier
    Abraldes, Juan G.
    Penas, Beatriz
    Berzigotti, Annalisa
    Deulofeu, Ramon
    Bosch, Jaume
    Albillos, Agustin
    Carles Garcia-Pagan, Joan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (07): : 985 - 992
  • [27] Angiotensin II receptor antagonist irbesartan in the treatment of chronic heart failure
    Belousov, YB
    Upnitsky, AA
    Khanina, NY
    KARDIOLOGIYA, 2000, 40 (10) : 88 - 91
  • [28] TREATMENT OF PORTOSYSTEMIC ENCEPHALOPATHY WITH THE BENZODIAZEPINE-RECEPTOR ANTAGONIST FLUMAZENIL (A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY)
    MEIER, R
    GYR, K
    HAUSSLER, R
    GASTROENTEROLOGY, 1994, 106 (04) : A942 - A942
  • [29] A PLACEBO-CONTROLLED DOUBLE-BLIND MULTICENTER STUDY OF CELIPROLOL IN THE TREATMENT OF MILD AND MODERATE HYPERTENSION
    CAPONE, P
    MAYOL, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 : S119 - S121
  • [30] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF KCL IN THE TREATMENT OF MILD HYPERTENSION
    SVETKEY, LP
    YARGER, WE
    FEUSSNER, JR
    DELONG, E
    KLOTMAN, PE
    HYPERTENSION, 1987, 9 (05) : 444 - 450
12345